Bi 10773, a sodium-glucose co-transporter inhibitor (SGLT-2), is safe and efficacious following 4-week treatment in patients with type 2 diabetes

Authors
Category Primary study
JournalDiabetes
Year 2010
This article has no abstract
Epistemonikos ID: 0fae889e2463604f3e098bc8db5ffec4484c36ca
First added on: Feb 06, 2025